17429101

Source:http://linkedlifedata.com/resource/pubmed/id/17429101

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0061928, umls-concept:C0085533, umls-concept:C0087111, umls-concept:C0746319, umls-concept:C1274040, umls-concept:C1280500, umls-concept:C1512890
pubmed:issue	7
pubmed:dateCreated	2007-8-6
pubmed:abstractText	The International Breast Cancer Study Group (IBCSG) conducted two complementary randomized trials to assess whether a treatment-free gap during adjuvant chemotherapy influenced outcome.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA-75362
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0923-7534
pubmed:author	pubmed-author:Castiglione-GertschMonicaM, pubmed-author:CoatesAlan SAS, pubmed-author:ColleoniMarcoM, pubmed-author:GelberRichard DRD, pubmed-author:GelberShariS, pubmed-author:GoldhirschAronA, pubmed-author:International Breast Cancer Study Group, pubmed-author:PaganiOliviaO, pubmed-author:PriceKaren NKN, pubmed-author:SimonciniEddaE
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1177-84
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:17429101-Adult, pubmed-meshheading:17429101-Aged, pubmed-meshheading:17429101-Antineoplastic Agents, Hormonal, pubmed-meshheading:17429101-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17429101-Breast Neoplasms, pubmed-meshheading:17429101-Chemotherapy, Adjuvant, pubmed-meshheading:17429101-Cyclophosphamide, pubmed-meshheading:17429101-Disease-Free Survival, pubmed-meshheading:17429101-Doxorubicin, pubmed-meshheading:17429101-Drug Administration Schedule, pubmed-meshheading:17429101-Epirubicin, pubmed-meshheading:17429101-Female, pubmed-meshheading:17429101-Fluorouracil, pubmed-meshheading:17429101-Humans, pubmed-meshheading:17429101-Kaplan-Meier Estimate, pubmed-meshheading:17429101-Lymphatic Metastasis, pubmed-meshheading:17429101-Methotrexate, pubmed-meshheading:17429101-Middle Aged, pubmed-meshheading:17429101-Neoplasm Recurrence, Local, pubmed-meshheading:17429101-Receptors, Estrogen, pubmed-meshheading:17429101-Tamoxifen
pubmed:year	2007
pubmed:articleTitle	Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.
pubmed:affiliation	Division of Medical Oncology, European Institute of Oncology, Milan, Italy. marco.colleoni@ieo.it
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural